Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries
Bisphosphonate (BP)-associated osteonecrosis of the jaw (ONJ) was first reported in oncology patients in 2003 and subsequently in osteoporosis patients in 2004. Since oral surgical procedures, such as tooth extraction, are also considered one of the major risk factors for ONJ, there is confusion amo...
Main Authors: | Akira Taguchi, Masataka Shiraki, Archie Morrison, Aliya A. Khan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-06-01
|
Series: | Osteoporosis and Sarcopenia |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405525517300134 |
Similar Items
-
Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents
by: Lukas Hauer, et al.
Published: (2020-03-01) -
Alendronate-Induced Osteonecrosis of the Jaw in an Elderly Female
by: Bi-Wei Jan, et al.
Published: (2012-06-01) -
Drug-induced osteonecrosis of the jaw: the state of the art
by: A. Fassio, et al.
Published: (2017-05-01) -
Development of Osteonecrosis of the Jaw in a Patient Receiving Oral Bisphosphonates for Osteoporosis: A Case Report
by: Sina Esmaeilzadeh, et al.
Published: (2014-08-01) -
Osteonecrosis of the jaw in a patient under treatment of osteoporosis with oral bisphosphonate
by: Marília A. Figueiredo, et al.
Published: (2021-01-01)